MedPath

Vernalis (R&D) Ltd.

🇬🇧United Kingdom
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.vernalis.com

Clinical Trials

10

Active:0
Completed:9

Trial Phases

2 Phases

Phase 1:6
Phase 2:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 1
6 (60.0%)
Phase 2
4 (40.0%)

A Study in Healthy Male Volunteers to Investigate a New Drug for the Treatment of Parkinson's Disease

Phase 1
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2016-05-06
Last Posted Date
2016-05-06
Lead Sponsor
Vernalis (R&D) Ltd
Target Recruit Count
6
Registration Number
NCT02764892

Safety, Tolerability, PK & Efficacy of V81444 in Volunteers With Attention Deficit/ Hyperactivity Disorder (ADHD)

Phase 1
Completed
Conditions
ADHD
Interventions
Drug: Placebo
First Posted Date
2014-10-01
Last Posted Date
2016-06-03
Lead Sponsor
Vernalis (R&D) Ltd
Target Recruit Count
31
Registration Number
NCT02253745
Locations
🇺🇸

Vince and Associates Clinical Research, Kansas City, Kansas, United States

Single and Multiple Ascending Dose Study of V158866 in Healthy Volunteers

Phase 1
Completed
Conditions
First in Man Study
Interventions
First Posted Date
2012-07-06
Last Posted Date
2012-07-11
Lead Sponsor
Vernalis (R&D) Ltd
Target Recruit Count
50
Registration Number
NCT01634529
Locations
🇬🇧

Hammersmith Medicines Research Limited, London, United Kingdom

A Clinical Trial to Find Out V81444's Side Effects and Blood Levels in Healthy Men

Phase 1
Completed
Conditions
Parkinson's Disease
Interventions
First Posted Date
2012-07-06
Last Posted Date
2012-07-10
Lead Sponsor
Vernalis (R&D) Ltd
Target Recruit Count
49
Registration Number
NCT01634568
Locations
🇬🇧

Hammersmith Medicines Research, London, United Kingdom

Phase II Open-Label Pilot Study of V3381 in Chronic Cough

Phase 2
Terminated
Conditions
Cough
First Posted Date
2011-07-25
Last Posted Date
2011-07-25
Lead Sponsor
Vernalis (R&D) Ltd
Target Recruit Count
12
Registration Number
NCT01401673
Locations
🇬🇧

South Manchester University Hospital, Manchester, United Kingdom

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.